[SCHEDULE 13G/A] Astria Therapeutics, Inc. SEC Filing
Astria Therapeutics Schedule 13G/A summary: Four reporting persons鈥擱A Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky and Rajeev Shah鈥攆iled a joint Schedule 13G amendment reporting that they do not beneficially own any shares of Astria Therapeutics common stock. The cover pages show aggregate beneficial ownership of 0 shares, representing 0.0% of the class, and no sole or shared voting or dispositive power is reported. The filing disclaims group status and incorporates a prior joint filing agreement by reference.
Riepilogo dell'emendamento Schedule 13G/A di Astria Therapeutics: Quattro soggetti obbligati alla comunicazione 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky e Rajeev Shah 鈥� hanno presentato congiuntamente un emendamento al Schedule 13G dichiarando di non detenere in via beneficiaria alcuna azione ordinarie di Astria Therapeutics. Le pagine di copertina indicano un possesso beneficiario aggregato pari a 0 azioni, corrispondente allo 0,0% della classe, e non risultano poteri di voto o dispositivi esclusivi o condivisi. La comunicazione esclude lo status di gruppo e incorpora per riferimento un precedente accordo congiunto di deposito.
Resumen del Schedule 13G/A de Astria Therapeutics: Cuatro declarantes 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky y Rajeev Shah 鈥� presentaron conjuntamente una enmienda al Schedule 13G en la que informan que no poseen de forma beneficiaria acciones ordinarias de Astria Therapeutics. Las p谩ginas de portada muestran una tenencia beneficiaria agregada de 0 acciones, que representan el 0,0% de la clase, y no se reportan poderes de voto ni de disposici贸n exclusivos ni compartidos. La presentaci贸n niega el estatus de grupo e incorpora por referencia un acuerdo conjunto previo.
Astria Therapeutics Schedule 13G/A 鞖旍暯: RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky, Rajeev Shah 霌� 雱� 氇呾潣 鞁犼碃鞚胳澊 瓿惦彊鞙茧 Schedule 13G 靾橃爼靹滊ゼ 鞝滌稖頃橃棳 Astria Therapeutics 氤错喌欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨 鞎婌潓鞚� 氤搓碃頄堨姷雼堧嫟. 響滌鞐愲姅 齑� 鞁れ 氤挫湢 欤检嫕 靾� 0欤�, 頃措嫻 韥措灅鞀れ潣 0.0%搿� 響滌嫓霅橃柎 鞛堨溂氅�, 雼弲 霕愲姅 瓿惦彊鞚� 鞚橁舶甓屄缝矘攵勱秾鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖靹滌棎電� 攴鸽９ 歆�鞙勲ゼ 攵�鞚疙晿氅� 鞚挫爠鞚� 瓿惦彊 鞝滌稖 頃╈潣毳� 彀戈碃搿� 韽暔頃橁碃 鞛堨姷雼堧嫟.
R茅sum茅 du Schedule 13G/A d'Astria Therapeutics聽: Quatre personnes d茅clarantes 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky et Rajeev Shah 鈥� ont d茅pos茅 conjointement un amendement au Schedule 13G d茅clarant qu'elles ne d茅tiennent aucun titre ordinaire d'Astria Therapeutics 脿 titre b茅n茅ficiaire. Les pages de garde indiquent une possession b茅n茅ficiaire agr茅g茅e de 0 actions, repr茅sentant 0,0% de la cat茅gorie, et aucun pouvoir de vote ou de disposition, ni individuel ni partag茅, n'est d茅clar茅. le d茅p么t d茅cline le statut de groupe et incorpore par r茅f茅rence un accord conjoint ant茅rieur.
Zusammenfassung des Schedule 13G/A von Astria Therapeutics: Vier meldepflichtige Personen 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky und Rajeev Shah 鈥� reichten gemeinsam eine 脛nderung des Schedule 13G ein und gaben an, keine Stammaktien von Astria Therapeutics als wirtschaftliche Eigent眉mer zu halten. Die Deckbl盲tter weisen eine aggregierte wirtschaftliche Beteiligung von 0 Aktien, entsprechend 0,0% der Klasse aus; alleinige oder gemeinsame Stimm- oder Verf眉gungsrechte werden nicht berichtet. Die Einreichung lehnt den Gruppenstatus ab und bezieht sich auf eine fr眉here gemeinsame Einreichungsvereinbarung.
- None.
- None.
Insights
TL;DR Reporting persons state zero beneficial ownership in Astria Therapeutics, so no investor position or control influence is indicated.
The Schedule 13G/A is a routine disclosure showing that RA Capital entities and two individuals hold no beneficial shares and report 0.0% ownership. From an investor-significance perspective this filing is neutral: it neither signals accumulation nor divestiture by these parties. The disclaimer of group status and cross-reference to a prior joint filing agreement are procedural and do not change the ownership picture.
TL;DR The filing documents no voting or dispositive power and disclaims group status, indicating no governance influence by the filers.
This amendment clarifies governance exposure: none of the reporting persons claims sole or shared voting or dispositive authority over Astria common stock. The explicit 0.0% ownership and the statement that securities are not held to influence control reinforce that these filers are not active participants in corporate governance. The referenced joint filing agreement is procedural for coordinated reporting.
Riepilogo dell'emendamento Schedule 13G/A di Astria Therapeutics: Quattro soggetti obbligati alla comunicazione 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky e Rajeev Shah 鈥� hanno presentato congiuntamente un emendamento al Schedule 13G dichiarando di non detenere in via beneficiaria alcuna azione ordinarie di Astria Therapeutics. Le pagine di copertina indicano un possesso beneficiario aggregato pari a 0 azioni, corrispondente allo 0,0% della classe, e non risultano poteri di voto o dispositivi esclusivi o condivisi. La comunicazione esclude lo status di gruppo e incorpora per riferimento un precedente accordo congiunto di deposito.
Resumen del Schedule 13G/A de Astria Therapeutics: Cuatro declarantes 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky y Rajeev Shah 鈥� presentaron conjuntamente una enmienda al Schedule 13G en la que informan que no poseen de forma beneficiaria acciones ordinarias de Astria Therapeutics. Las p谩ginas de portada muestran una tenencia beneficiaria agregada de 0 acciones, que representan el 0,0% de la clase, y no se reportan poderes de voto ni de disposici贸n exclusivos ni compartidos. La presentaci贸n niega el estatus de grupo e incorpora por referencia un acuerdo conjunto previo.
Astria Therapeutics Schedule 13G/A 鞖旍暯: RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky, Rajeev Shah 霌� 雱� 氇呾潣 鞁犼碃鞚胳澊 瓿惦彊鞙茧 Schedule 13G 靾橃爼靹滊ゼ 鞝滌稖頃橃棳 Astria Therapeutics 氤错喌欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨 鞎婌潓鞚� 氤搓碃頄堨姷雼堧嫟. 響滌鞐愲姅 齑� 鞁れ 氤挫湢 欤检嫕 靾� 0欤�, 頃措嫻 韥措灅鞀れ潣 0.0%搿� 響滌嫓霅橃柎 鞛堨溂氅�, 雼弲 霕愲姅 瓿惦彊鞚� 鞚橁舶甓屄缝矘攵勱秾鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖靹滌棎電� 攴鸽９ 歆�鞙勲ゼ 攵�鞚疙晿氅� 鞚挫爠鞚� 瓿惦彊 鞝滌稖 頃╈潣毳� 彀戈碃搿� 韽暔頃橁碃 鞛堨姷雼堧嫟.
R茅sum茅 du Schedule 13G/A d'Astria Therapeutics聽: Quatre personnes d茅clarantes 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky et Rajeev Shah 鈥� ont d茅pos茅 conjointement un amendement au Schedule 13G d茅clarant qu'elles ne d茅tiennent aucun titre ordinaire d'Astria Therapeutics 脿 titre b茅n茅ficiaire. Les pages de garde indiquent une possession b茅n茅ficiaire agr茅g茅e de 0 actions, repr茅sentant 0,0% de la cat茅gorie, et aucun pouvoir de vote ou de disposition, ni individuel ni partag茅, n'est d茅clar茅. le d茅p么t d茅cline le statut de groupe et incorpore par r茅f茅rence un accord conjoint ant茅rieur.
Zusammenfassung des Schedule 13G/A von Astria Therapeutics: Vier meldepflichtige Personen 鈥� RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky und Rajeev Shah 鈥� reichten gemeinsam eine 脛nderung des Schedule 13G ein und gaben an, keine Stammaktien von Astria Therapeutics als wirtschaftliche Eigent眉mer zu halten. Die Deckbl盲tter weisen eine aggregierte wirtschaftliche Beteiligung von 0 Aktien, entsprechend 0,0% der Klasse aus; alleinige oder gemeinsame Stimm- oder Verf眉gungsrechte werden nicht berichtet. Die Einreichung lehnt den Gruppenstatus ab und bezieht sich auf eine fr眉here gemeinsame Einreichungsvereinbarung.
FAQ
What does the Schedule 13G/A filed for Astria Therapeutics (ATXS) report?
Who are the reporting persons on this Schedule 13G/A for ATXS?
Do the reporting persons claim any voting or dispositive power over ATXS shares?
Does the filing state the reporting persons form a group to influence control of Astria?
Is there any indication the reporting persons hold shares on behalf of others or over 5% of the class?
